play_arrow
play_arrow
AVCJ Private Equity & Venture Forum 2022
Asia's premier private equity & venture event for the last 35 years
LIVE Broadcast & In Person
Four Seasons Hotel, Singapore & Online
16
Nov
Investment Summit Track 2
Venue: Crescent Ballroom - 2/F
Multi-purpose Room: 3/F (open for all AVCJ Forum Delegates)
Speaker Lounge: Autumn Chrysanthemum - 2/F
-
Agenda14.15 - 15.00SGT
Track 2: Global venture: The view from the top (Venue: Crescent Ballroom - 2/F)
- Which verticals have the most potential in a post-pandemic world?
- Are investors approaching due diligence and risk assessment in a different way?
- To what extent can deal structuring avert down rounds?
- Where will liquidity come from in the absence of IPOs?
16.00 - 17.00SGTTrack 2: Special situations: New opportunities, new playbooks (Venue: Crescent Ballroom - 2/F)
- Is now finally the time for distress strategies?
- Which geographies and sectors are most attractive?
- What are the prevalent trends in transaction structuring?
- Can global investors become suitably localised for special situations in Asia?
Loading feed
Lead Sponsors
Asia Series Sponsor
Knowledge Partner
Co-Sponsors
Legal Sponsors
Networking Coffee Break Sponsor
Gala Cocktail Sponsor
Gala Dinner Sponsor
14.15
- 15.00
SGT
Track 2: Global venture: The view from the top (Venue: Crescent Ballroom - 2/F)
- Which verticals have the most potential in a post-pandemic world?
- Are investors approaching due diligence and risk assessment in a different way?
- To what extent can deal structuring avert down rounds?
- Where will liquidity come from in the absence of IPOs?
16.00
- 17.00
SGT
Track 2: Special situations: New opportunities, new playbooks (Venue: Crescent Ballroom - 2/F)
- Is now finally the time for distress strategies?
- Which geographies and sectors are most attractive?
- What are the prevalent trends in transaction structuring?
- Can global investors become suitably localised for special situations in Asia?
Confirm cancellation
Something went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
CloseSign-up to join the ION Analytics Community to:
- Register for events
- Access market insights
- Download reports
Will Cai is based in Cooley’s Hong Kong office, he is the head of Cooley’s Asia capital markets practice and co-chair of Cooley’s China Corporate practice. He represents issuers and global investment banks in US and Hong Kong capital market transactions. He also advises private equity funds and multinationals in their investments in Asia region, as well as Asia companies in their cross-border M&A activities.
Will has worked on over 70 successful IPOs in the US and Hong Kong capital markets in the last decade, with a focus on technology and new economy companies. In addition, Will has represented a significant number of leading new economy companies in their M&A transactions, including a number of landmark deals. The deals he has worked on over the years have garnered a number of rankings and accolades including "M&A Deal of the Year - Premium" by Asian Legal Business China Law Awards 2024, “Equity Securities Deal of the Year 2022” by China Law & Practice Awards, "Best IPO of 2017" by FinanceAsia Magazine, "Equity Deal of the Year for 2017" by the IFLR Asia Awards, the largest technology IPO in Hong Kong in 2017, "Deal of the Year 2015, 2016 and 2023" by China Business Law Journal, and "Deal of the Year 2015" by Asian-MENA Counsel magazine.
From 1997 to 2003, Will worked for the Supreme People’s Court of China, where he acquired extensive experience and knowledge of the Chinese judiciary.
Will received his JD from Stanford Law School and LLB from China University of Political Science and Law. He is admitted to practice in California and Hong Kong. Will is a native Mandarin speaker and is fluent in English. He is admitted to practice in California and is a solicitor of Hong Kong.
Nisa Leung is Managing Partner of Qiming Venture Partners, leading its health care investments. Qiming Venture Partners is a leading investment firm in China with USD9.5B AUM raised and over 530 portfolio companies.
Nisa has been recognized by the Forbes Global 100 VC Midas List in 2019, 2020, 2021, 2022 and 2023 and named Best Women VCs List by Forbes China #1 in 2022 and Most Powerful Women in Business by Fortune China in 2022.
She currently sits on the board of Zai Lab (NASDAQ:ZLAB; HKSE:9688), CanSino Biologics (SSE:688185; HKSE:6185), Caidya, Chain Medical Labs, Belief BioMed, Zencore Biologics, Valgen MedTech, Alamar Biosciences among others.
Nisa earned her MBA from Stanford Graduate School of Business and a BS from Cornell University. She is currently visiting lecturer at Harvard Law School, member of Stanford Graduate School of Business Advisory Council and serves as an independent non-executive director of the Hong Kong Exchanges and Clearing Limited (“HKEX”) and Hong Kong Palace Museum.
Dominic is a Partner at AVP and is in charge of their fund investing activities across primary fund commitments, secondaries and co-investments. He sits on LPACs of several US and European VC funds. He joined AVP in 2017 and is based in London. Prior to AVP, Dominic was a Vice President at Adams Street Partners in the Global Primary Investment team based in London.
Dominic gained extensive experience evaluating funds ranging from technology and life sciences venture capital, growth capital and buyout funds, as well as monitoring investments as a member of Advisory Boards. Before that, Dominic worked at EY in their Financial Services Business Modelling team where he worked on transactions in the banking and asset management sub-sectors.
Dominic is a Chartered Accountant with the Institute of Chartered Accountants of Scotland. He holds a First Class degree in Accounting, Auditing & Finance from Lancaster University Management School.
Spencer Greene has been a general partner at TSVC, a Silicon Valley-based seed-stage venture firm, since 2018. He leads the firm's digital health and medtech investing. Prior to joining TSVC, Spencer was a startup founder and tech operating executive for 30 years, with two successful exits as founder. Spencer also spent 12 years at Juniper Networks in various roles, including head of Strategy and Corporate Development.
Mr. Kei Chua joined Bain Capital Credit in 2016. He is a Managing Director based in Bain Capital Credit’s Hong Kong office and is a member of the Distressed and Special Situations team focused on special situations and portfolio investing. Previously, Mr. Chua was the co-head of Asia for Mount Kellett Capital focused on special situations and distressed investing. Prior to that, Mr. Chua was a partner with Unitas Capital (fka J.P. Morgan Partners Asia) where he was responsible for investments in Greater China and Southeast Asia. Prior to that, Mr. Chua worked at Cerberus Capital and DLJ in Hong Kong and New York.
Education: Mr. Chua received a B.A. from Columbia College.
- Heng is an MD for Private Credit and Special Situations in Asia Pacific for Strategic Investment Group (SIG) , Deutsche Bank
Part of his responsibilities include sourcing, structuring, syndication and portfolio management.
- Private Credit / Special Situations includes distressed debt, rescue financings, direct lending, stressed par loans and Pre-IPO financings
- Heng has been with SIG since 2008
- Heng is on the Supervisory Board of Huarong Rongde, a JV between SIG and Huarong International (AMC)
- Prior to joining SIG in 2008, Heng was with Bank of America in London and Lehman Brothers in New York
- Heng graduated from Williams College with a BA in Economics in 2001
- Heng is fluent in both English and Mandarin
Grainne has over 20 years’ experience in international banking and private equity. She has advised listed corporates and private equity on their investments in Europe, the U.S. and Asia. Based in Singapore for the last 12 years, Grainne currently works in Standard Chartered Bank focusing on special assets management. Prior to that, she was Director of Investments for Fine Grain Property, a PE real estate investor and operator. Before moving to Singapore, Grainne was a Director in the corporate finance boutique, DC Advisory in London where she advised on billions of dollars of complex, multi-jurisdictional restructurings and was responsible for returning numerous clients to financial health. Prior to that, Grainne worked in the Allied Irish Banks in London focusing on restructuring and portfolio management. She is also a fellow of the Institute of Chartered Accountants of Ireland and trained as a Chartered Accountant with KPMG in Dublin, Ireland.
Luc has over 20 years of experience as a financial journalist in Asia covering fixed income, credit derivatives and distressed debt markets. He joined Debtwire in 2006 as Managing Editor for the Asia-Pacific region and now is responsible for a team of 14 journalists and five analysts that cover primarily the stressed/distressed debt, high yield and primary debt markets. Luc first started covering distressed debt markets in 1989 as a reporter for IFR in Japan. In 1998 he initiated and developed coverage of the Asian distressed debt markets for IFR Asia.
Mr. Goel is a Partner in the Ares SSG Group, where he is a member of the Investment Committee and oversees the groups' investments in India. Prior to joining Ares in 2020, Mr. Goel worked as a Managing Director of the SSG Group since 2009 and was instrumental in growing the firm's India business, including identifying opportunities and structuring investments and asset management. He has deep experience in the structuring of private credit transactions, special situation investments and has led SSG's private lending strategy in the region since its inception. Mr. Goel began his career in 2002 at Lehman Brothers in Tokyo and later worked in the bank's Hong Kong office, where he focused on principal positions related to structured credit and stressed convertible bonds. Mr. Goel holds a B.Tech. from the Indian Institute of Technology, Delhi in Chemical Engineering and an M.B.A. from the Indian Institute of Management. Mr. Goel is a CFA® charterholder.
Will Cai is based in Cooley’s Hong Kong office, he is the head of Cooley’s Asia capital markets practice and co-chair of Cooley’s China Corporate practice. He represents issuers and global investment banks in US and Hong Kong capital market transactions. He also advises private equity funds and multinationals in their investments in Asia region, as well as Asia companies in their cross-border M&A activities.
Will has worked on over 70 successful IPOs in the US and Hong Kong capital markets in the last decade, with a focus on technology and new economy companies. In addition, Will has represented a significant number of leading new economy companies in their M&A transactions, including a number of landmark deals. The deals he has worked on over the years have garnered a number of rankings and accolades including "M&A Deal of the Year - Premium" by Asian Legal Business China Law Awards 2024, “Equity Securities Deal of the Year 2022” by China Law & Practice Awards, "Best IPO of 2017" by FinanceAsia Magazine, "Equity Deal of the Year for 2017" by the IFLR Asia Awards, the largest technology IPO in Hong Kong in 2017, "Deal of the Year 2015, 2016 and 2023" by China Business Law Journal, and "Deal of the Year 2015" by Asian-MENA Counsel magazine.
From 1997 to 2003, Will worked for the Supreme People’s Court of China, where he acquired extensive experience and knowledge of the Chinese judiciary.
Will received his JD from Stanford Law School and LLB from China University of Political Science and Law. He is admitted to practice in California and Hong Kong. Will is a native Mandarin speaker and is fluent in English. He is admitted to practice in California and is a solicitor of Hong Kong.
Nisa Leung is Managing Partner of Qiming Venture Partners, leading its health care investments. Qiming Venture Partners is a leading investment firm in China with USD9.5B AUM raised and over 530 portfolio companies.
Nisa has been recognized by the Forbes Global 100 VC Midas List in 2019, 2020, 2021, 2022 and 2023 and named Best Women VCs List by Forbes China #1 in 2022 and Most Powerful Women in Business by Fortune China in 2022.
She currently sits on the board of Zai Lab (NASDAQ:ZLAB; HKSE:9688), CanSino Biologics (SSE:688185; HKSE:6185), Caidya, Chain Medical Labs, Belief BioMed, Zencore Biologics, Valgen MedTech, Alamar Biosciences among others.
Nisa earned her MBA from Stanford Graduate School of Business and a BS from Cornell University. She is currently visiting lecturer at Harvard Law School, member of Stanford Graduate School of Business Advisory Council and serves as an independent non-executive director of the Hong Kong Exchanges and Clearing Limited (“HKEX”) and Hong Kong Palace Museum.
Dominic is a Partner at AVP and is in charge of their fund investing activities across primary fund commitments, secondaries and co-investments. He sits on LPACs of several US and European VC funds. He joined AVP in 2017 and is based in London. Prior to AVP, Dominic was a Vice President at Adams Street Partners in the Global Primary Investment team based in London.
Dominic gained extensive experience evaluating funds ranging from technology and life sciences venture capital, growth capital and buyout funds, as well as monitoring investments as a member of Advisory Boards. Before that, Dominic worked at EY in their Financial Services Business Modelling team where he worked on transactions in the banking and asset management sub-sectors.
Dominic is a Chartered Accountant with the Institute of Chartered Accountants of Scotland. He holds a First Class degree in Accounting, Auditing & Finance from Lancaster University Management School.
Spencer Greene has been a general partner at TSVC, a Silicon Valley-based seed-stage venture firm, since 2018. He leads the firm's digital health and medtech investing. Prior to joining TSVC, Spencer was a startup founder and tech operating executive for 30 years, with two successful exits as founder. Spencer also spent 12 years at Juniper Networks in various roles, including head of Strategy and Corporate Development.
Mr. Kei Chua joined Bain Capital Credit in 2016. He is a Managing Director based in Bain Capital Credit’s Hong Kong office and is a member of the Distressed and Special Situations team focused on special situations and portfolio investing. Previously, Mr. Chua was the co-head of Asia for Mount Kellett Capital focused on special situations and distressed investing. Prior to that, Mr. Chua was a partner with Unitas Capital (fka J.P. Morgan Partners Asia) where he was responsible for investments in Greater China and Southeast Asia. Prior to that, Mr. Chua worked at Cerberus Capital and DLJ in Hong Kong and New York.
Education: Mr. Chua received a B.A. from Columbia College.
- Heng is an MD for Private Credit and Special Situations in Asia Pacific for Strategic Investment Group (SIG) , Deutsche Bank
Part of his responsibilities include sourcing, structuring, syndication and portfolio management.
- Private Credit / Special Situations includes distressed debt, rescue financings, direct lending, stressed par loans and Pre-IPO financings
- Heng has been with SIG since 2008
- Heng is on the Supervisory Board of Huarong Rongde, a JV between SIG and Huarong International (AMC)
- Prior to joining SIG in 2008, Heng was with Bank of America in London and Lehman Brothers in New York
- Heng graduated from Williams College with a BA in Economics in 2001
- Heng is fluent in both English and Mandarin
Grainne has over 20 years’ experience in international banking and private equity. She has advised listed corporates and private equity on their investments in Europe, the U.S. and Asia. Based in Singapore for the last 12 years, Grainne currently works in Standard Chartered Bank focusing on special assets management. Prior to that, she was Director of Investments for Fine Grain Property, a PE real estate investor and operator. Before moving to Singapore, Grainne was a Director in the corporate finance boutique, DC Advisory in London where she advised on billions of dollars of complex, multi-jurisdictional restructurings and was responsible for returning numerous clients to financial health. Prior to that, Grainne worked in the Allied Irish Banks in London focusing on restructuring and portfolio management. She is also a fellow of the Institute of Chartered Accountants of Ireland and trained as a Chartered Accountant with KPMG in Dublin, Ireland.
Luc has over 20 years of experience as a financial journalist in Asia covering fixed income, credit derivatives and distressed debt markets. He joined Debtwire in 2006 as Managing Editor for the Asia-Pacific region and now is responsible for a team of 14 journalists and five analysts that cover primarily the stressed/distressed debt, high yield and primary debt markets. Luc first started covering distressed debt markets in 1989 as a reporter for IFR in Japan. In 1998 he initiated and developed coverage of the Asian distressed debt markets for IFR Asia.
Mr. Goel is a Partner in the Ares SSG Group, where he is a member of the Investment Committee and oversees the groups' investments in India. Prior to joining Ares in 2020, Mr. Goel worked as a Managing Director of the SSG Group since 2009 and was instrumental in growing the firm's India business, including identifying opportunities and structuring investments and asset management. He has deep experience in the structuring of private credit transactions, special situation investments and has led SSG's private lending strategy in the region since its inception. Mr. Goel began his career in 2002 at Lehman Brothers in Tokyo and later worked in the bank's Hong Kong office, where he focused on principal positions related to structured credit and stressed convertible bonds. Mr. Goel holds a B.Tech. from the Indian Institute of Technology, Delhi in Chemical Engineering and an M.B.A. from the Indian Institute of Management. Mr. Goel is a CFA® charterholder.
Mr. Goel is a Partner in the Ares SSG Group, where he is a member of the Investment Committee and oversees the groups' investments in India. Prior to joining Ares in 2020, Mr. Goel worked as a Managing Director of the SSG Group since 2009 and was instrumental in growing the firm's India business, including identifying opportunities and structuring investments and asset management. He has deep experience in the structuring of private credit transactions, special situation investments and has led SSG's private lending strategy in the region since its inception. Mr. Goel began his career in 2002 at Lehman Brothers in Tokyo and later worked in the bank's Hong Kong office, where he focused on principal positions related to structured credit and stressed convertible bonds. Mr. Goel holds a B.Tech. from the Indian Institute of Technology, Delhi in Chemical Engineering and an M.B.A. from the Indian Institute of Management. Mr. Goel is a CFA® charterholder.
Dominic is a Partner at AVP and is in charge of their fund investing activities across primary fund commitments, secondaries and co-investments. He sits on LPACs of several US and European VC funds. He joined AVP in 2017 and is based in London. Prior to AVP, Dominic was a Vice President at Adams Street Partners in the Global Primary Investment team based in London.
Dominic gained extensive experience evaluating funds ranging from technology and life sciences venture capital, growth capital and buyout funds, as well as monitoring investments as a member of Advisory Boards. Before that, Dominic worked at EY in their Financial Services Business Modelling team where he worked on transactions in the banking and asset management sub-sectors.
Dominic is a Chartered Accountant with the Institute of Chartered Accountants of Scotland. He holds a First Class degree in Accounting, Auditing & Finance from Lancaster University Management School.
Grainne has over 20 years’ experience in international banking and private equity. She has advised listed corporates and private equity on their investments in Europe, the U.S. and Asia. Based in Singapore for the last 12 years, Grainne currently works in Standard Chartered Bank focusing on special assets management. Prior to that, she was Director of Investments for Fine Grain Property, a PE real estate investor and operator. Before moving to Singapore, Grainne was a Director in the corporate finance boutique, DC Advisory in London where she advised on billions of dollars of complex, multi-jurisdictional restructurings and was responsible for returning numerous clients to financial health. Prior to that, Grainne worked in the Allied Irish Banks in London focusing on restructuring and portfolio management. She is also a fellow of the Institute of Chartered Accountants of Ireland and trained as a Chartered Accountant with KPMG in Dublin, Ireland.
- Heng is an MD for Private Credit and Special Situations in Asia Pacific for Strategic Investment Group (SIG) , Deutsche Bank
Part of his responsibilities include sourcing, structuring, syndication and portfolio management.
- Private Credit / Special Situations includes distressed debt, rescue financings, direct lending, stressed par loans and Pre-IPO financings
- Heng has been with SIG since 2008
- Heng is on the Supervisory Board of Huarong Rongde, a JV between SIG and Huarong International (AMC)
- Prior to joining SIG in 2008, Heng was with Bank of America in London and Lehman Brothers in New York
- Heng graduated from Williams College with a BA in Economics in 2001
- Heng is fluent in both English and Mandarin
Mr. Kei Chua joined Bain Capital Credit in 2016. He is a Managing Director based in Bain Capital Credit’s Hong Kong office and is a member of the Distressed and Special Situations team focused on special situations and portfolio investing. Previously, Mr. Chua was the co-head of Asia for Mount Kellett Capital focused on special situations and distressed investing. Prior to that, Mr. Chua was a partner with Unitas Capital (fka J.P. Morgan Partners Asia) where he was responsible for investments in Greater China and Southeast Asia. Prior to that, Mr. Chua worked at Cerberus Capital and DLJ in Hong Kong and New York.
Education: Mr. Chua received a B.A. from Columbia College.
Luc has over 20 years of experience as a financial journalist in Asia covering fixed income, credit derivatives and distressed debt markets. He joined Debtwire in 2006 as Managing Editor for the Asia-Pacific region and now is responsible for a team of 14 journalists and five analysts that cover primarily the stressed/distressed debt, high yield and primary debt markets. Luc first started covering distressed debt markets in 1989 as a reporter for IFR in Japan. In 1998 he initiated and developed coverage of the Asian distressed debt markets for IFR Asia.
Nisa Leung is Managing Partner of Qiming Venture Partners, leading its health care investments. Qiming Venture Partners is a leading investment firm in China with USD9.5B AUM raised and over 530 portfolio companies.
Nisa has been recognized by the Forbes Global 100 VC Midas List in 2019, 2020, 2021, 2022 and 2023 and named Best Women VCs List by Forbes China #1 in 2022 and Most Powerful Women in Business by Fortune China in 2022.
She currently sits on the board of Zai Lab (NASDAQ:ZLAB; HKSE:9688), CanSino Biologics (SSE:688185; HKSE:6185), Caidya, Chain Medical Labs, Belief BioMed, Zencore Biologics, Valgen MedTech, Alamar Biosciences among others.
Nisa earned her MBA from Stanford Graduate School of Business and a BS from Cornell University. She is currently visiting lecturer at Harvard Law School, member of Stanford Graduate School of Business Advisory Council and serves as an independent non-executive director of the Hong Kong Exchanges and Clearing Limited (“HKEX”) and Hong Kong Palace Museum.
Spencer Greene has been a general partner at TSVC, a Silicon Valley-based seed-stage venture firm, since 2018. He leads the firm's digital health and medtech investing. Prior to joining TSVC, Spencer was a startup founder and tech operating executive for 30 years, with two successful exits as founder. Spencer also spent 12 years at Juniper Networks in various roles, including head of Strategy and Corporate Development.
Will Cai is based in Cooley’s Hong Kong office, he is the head of Cooley’s Asia capital markets practice and co-chair of Cooley’s China Corporate practice. He represents issuers and global investment banks in US and Hong Kong capital market transactions. He also advises private equity funds and multinationals in their investments in Asia region, as well as Asia companies in their cross-border M&A activities.
Will has worked on over 70 successful IPOs in the US and Hong Kong capital markets in the last decade, with a focus on technology and new economy companies. In addition, Will has represented a significant number of leading new economy companies in their M&A transactions, including a number of landmark deals. The deals he has worked on over the years have garnered a number of rankings and accolades including "M&A Deal of the Year - Premium" by Asian Legal Business China Law Awards 2024, “Equity Securities Deal of the Year 2022” by China Law & Practice Awards, "Best IPO of 2017" by FinanceAsia Magazine, "Equity Deal of the Year for 2017" by the IFLR Asia Awards, the largest technology IPO in Hong Kong in 2017, "Deal of the Year 2015, 2016 and 2023" by China Business Law Journal, and "Deal of the Year 2015" by Asian-MENA Counsel magazine.
From 1997 to 2003, Will worked for the Supreme People’s Court of China, where he acquired extensive experience and knowledge of the Chinese judiciary.
Will received his JD from Stanford Law School and LLB from China University of Political Science and Law. He is admitted to practice in California and Hong Kong. Will is a native Mandarin speaker and is fluent in English. He is admitted to practice in California and is a solicitor of Hong Kong.